Role of tachykinins in bronchial hyper-responsiveness

Clinical and Experimental Pharmacology and Physiology

Volumn 24, Issue 3-4, 1997, Pages 273-280

  Reynolds, Paul N ^a   Holmes, Mark D ^a   Scicchitano, Raffaele ^a  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

Airway obstruction; Asthma; Bronchial hyperresponsiveness; Capsaicin; Inflammation; Neuropeptides; Neutral endopeptidases; Sensory nerves; Substance P; Tachykinins

Indexed keywords

2 BENZHYDRYL 3 (2 METHOXYBENZYLAMINO) 1 AZABICYCLO[2.2.2]OCTANE; 3 (2 METHOXYBENZYLAMINO) 2 PHENYLPIPERIDINE; FK 224; NEDOCROMIL; TACHYKININ; TACHYKININ RECEPTOR; TACHYKININ RECEPTOR ANTAGONIST;

ASTHMA; BRONCHUS HYPERREACTIVITY; CONFERENCE PAPER; DRUG RECEPTOR BINDING; HUMAN; HUMAN TISSUE; INFLAMMATION; MUSCLE CONTRACTION; SMOOTH MUSCLE FIBER;

EID: 0030984636     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1997.tb01819.x     Document Type: Conference Paper

References (85)

1. Karlsson J-A, Sant'ambrogio G, Widdcombe J. Afferent neural pathways in cough and reflex bronchoconstriction. J. Appl. Pliysiol. 1988; 65: 1007-23.
2. Lundberg JM, Hökfelt T, Martling CR, Saria A, Cuello C. Substance P-immunoreacti ve sensory nerves in the lower respiratory tract of various mammals including man. Cell Tissue Res. 1984; 235; 251-61.
3. Holzer P. Local effector functions of capsaicin-sensitive sensory nerve endings: Involvement of tachykinins, calcitonin gene-related peptide and other neuropcptides. Neuroscience 1988; 24: 739-68.
4. Lundberg JM. Tachykinins, sensory nerves, and asthma: An overview. Can. J. Physiol Phannacol. 1995; 73: 908-14.
5. Lundberg JM, Saria A. Capsaicin induced desensitisation of the airway mucosa to cigarette smoke, mechanical and chemical irritants. Nature 1983; 302: 251-3.
6. Forsberg K, Karlsson J-A. Cough induced by stimulation of capsaicin sensitive nerves in conscious guinea pigs. Acta Pliysiol. Scand. 1986; 128: 319-20.
7. Matsuse T, Thompson RJ, Chen X-R, Salari H, Schellenberg RR. Capsaicin inhibits airway hyperresponsiveness but not lipoxygenase activity or eosinophilia after repeated aerosolised antigen in guinea pigs. Am. Rev. Resp. Dis. 1991; 144: 368-72.
8. Warm M do P, Maldonado EAL, Fernezlian SM et al. Neurokinin depletion attenuates pulmonary changes induced by antigen challenge in sensitised guinea pigs. Am. J. Pliysiol 1995; 268: L781-8.
9. Rice A, Holmes M, Thornton A, Reynolds P, Scicchitano R. Tachykinins contribute to immediate allergic airways response in sheep. Am. J. Respir. Crit. Care Med. 1995; 151: A346.
10. Alving K, Matran R, Lacroix JS, Lundberg M. Capsaicin and histamine antagonist-sensitive mechanisms in the immediate allergic reaction of pig airways. Acta Pliysiol. Scand. 1990; 138: 49-60.
11. Fuller RW, Dixon CM, Bames PJ. Bronchoconstrictor response to inhaled capsaicin in man. J. Appl. Pliysiol. 1985; 58: 1080-4.
12. Karlsson J-A. A role for capsaicin sensitive, tachykinin containing nerves
13. in chronic coughing and sneezing but not in asthma: A hypothesis. Thorax 1993; 48: 396-400.
14. Philip G, Sanico AM, Togias A. Inflammatory cellular influx following capsaicin nasal challenge. Am. J. Respir. Crit. Care Med. 1996; 153: 1222-9.
15. Winning AJ, Hamilton RD, Shea S, Guz A. Respiratory and cardiovascular effects of central and peripheral injection of capsaicin in man: Evidence for pulmonary chemosensitivity. din. Sei. 1986; 71: 519-26.
16. Otsuka M, Yoshioka K. Neurotransmitter functions of mammalian tachykinins. Physiol. Rev. 1993; 73: 270-308.
17. Heike CJ, Krause JE, Mantyh PW, Couture R, Bannon MJ. Diversity in mammalian tachykinin peptidergic neurons: Multiple peptides, receptors, and regulatory mechanisms. FASEB J.-1990; 4: 1606-15.
18. MacDonald MR, Takeda J, Rice CM, Krause JE. Multiple tachykinins are produced and secreted upon post-translational processing of the three substance P precursor proteins, α, β and γ preprotachykinin. J. Biol. Chem. 1989; 264: 15 578-92.
19. Mussap CJ, Geraghty DP, Burcher E. Tachykinin receptors: A radioligand binding perspective. J. Neurochem. 1993; 60: 1987-2009.
20. Von Euler US, Gaddum JH. An unidentified depressor substance in certain tissue extracts. J. Physiol. 1931; 72: 74-86.
21. Lembeck F. Zur Frage Der Zentralen Übertragung afferenter Impulse. III Mitteilung. Das Vorkommen und die Bedeutung der Substanz P in den dorsalen Wurzeln des Rückenmarks. Arch. Exp. Pathol. Phannakol. 1953; 219: 197-213.
22. Konishi S, Otsuka M. The effects of substance P and other peptides on spinal neurons of the frog. Brain Res. 1974; 65: 397-410.
23. Chang MM, Leeman SE, Niai HD. Amino acid sequence of substance P. Nature New Biol. 1971 ; 232: 86-7.
24. Nakanishi S, Nakajima Y, Yokota Y. Signal transduction and ligand binding domains of the tachykinin receptors. Regal. Pept. 1993; 46: 37-42.
25. Martling C-R, Theodorsson-Norheim E, Lundberg JM. Occurrence and effects of multiple tachykinins: Substance P, neurokinin A and neuropeptide K in human lower airways. Life Sei. 1987; 40: 1633-43.
26. Carstairs JR, Barnes PJ. Autoradiographic mapping of substance P receptors in lung. Ear. J. Phannacol. 1986; 127: 295-6.
27. Reynolds PN, Scicchitano R, Holmes M. Glucocorticoid modulation of tachykinin receptor expression in human airway epithelium. Am. J. Respir. Crit. Care Med. 1995; 151: A174.
28. Bai TR, Zhou D, Weir T et al. Substance P (NKi)- and neurokinin A (NKi)-receptor gène expression in inflammatory airways diseases. Am. J. Physiol. 1995; 269: L309-17.
29. Ichikawa S, Sreedharan SP, Owen RL, Goetzl EJ. Immunochemical localisation of type I VIP receptor and NKi-type substance P receptor in rat lung. Am. J. Physiol. 1995; 268: L584-8.
30. Bowden JJ, Baluk P, Lefevre PM, Vigna SR, McDonald DM. Substance P (NKi) receptor immunoreactivity on endothelial cells on the rat trachéal mucosa. Am. J. Physiol. 1996; 270: L404-14.
31. Joos G, Pauwels R, Van Der Straten M. The effect of inhaled substance P and neurokinin A on the airways of normal and asthmatic subjects. Thorax 1987; 42: 779-83.
32. Cheung D, Van Der Veen H, den Hartigh J, Dijkman JH, Sterk PJ. Effect of inhaled substance P on airway responsiveness to methacholine in asthmatic subjects m vivo. J. Appl. Physiol. 1994; 77: 1325-32.
33. Cheung D, Bel EH, Den Hartigh J, Dijkman JH, Sterk PJ. The effect of an inhaled neutral endopeptidase inhibitor, thiorphan, on airway responses to neurokinin A in normal humans in vivo. Am. Rev. Respir. Dis. 1992; 145: 1275-80.
34. Cheung D, Timmers MC, Zwinderman AH, Den Hartigh J, Dijkman JH, Sterk PJ. Neutral endopeptidase activity and airway hyperresponsiveness to neurokinin A in asthmatic subjects fn vivo. Am. Rev. Respir. Dis. 1993; 148: 1467-73.
35. Crimi N, Palermo F, Oliver! R etal. Influence of antihistamine (astemizole) and anticholinergic drugs (ipratropium bromide) on bronchoconstriction induced by substance P. Ann. Allergy 1990; 65: 115-20.
36. Ad enier C, Naline E, Toty L et al. Effects on the isolated human bronchus of SR 48968, a potent and selective nonpeptide antagonist of the neurokininA(NK2) receptors./4m. Rev. Respir. Dis. 1992; 146: 1177-81.
37. Burcher E, Alouan LA, Johnson PR, Black JL. Neuropeptide gamma, the most potent contractile tachykinin in human isolated bronchus, acts via a 'non-classical' NK2 receptor. Neuropeptides 1991; 20: 79-82.
38. Abdellaziz B-J, Marthan R, Rossetti M, Savineau J-P. Effect of passive sensitisation on the mechanical activity of human isolated bronchial smooth muscle induced by substance P, neurokinin A and VIP. Br. J. Phannacol. 1993; 109: 131-6.
39. Joos GF, Germonpre PR, Kips JC, Peleman RA, Pauwels RA. Sensory neuropeptides and the human lower airways: Present state and future directions. Eur. Respir. J. 1994; 7: 1161-71.
40. Lundberg JM, Saria A. Polypeptide containing neurons in airway smooth muscle. Anna. Rev. Physiol. 1987; 49: 557-72.
41. Belvisi MG, Patacchini R, Barnes PJ, Maggi CA. Facilitatory effects of selective agonists for tachykinin receptors on cholinergic neurotransmission: Evidence for species differences. Br. J. Phannacol. 1994; 111: 103-10.
42. Reynolds A, Scicchitano R, Holmes M, Armour C. NK2 receptors predominate in the sheep trachea. Anst. N.Z. J. Med. 1995; 25: 414.
43. Devillier P, Acker GM, Advenier C, Marsac J, Regoli D, Frossard N. Activation of neurokinin NK-1 receptors induces relaxation of rat trachea through release of prostaglandin £2. J. Phannacol. Exp. Ther. 1992; 263: 767-72.
44. Bertrand C, Tschirhart E. Epithelial factors: Modulation of the airway smooth muscle tone. Fimdam. Clin. Phannacol. 1993; 7: 261-73.
45. James AL, Pare PD, Hogg JC. The mechanics of airway narrowing in asthma. Am. Rev. Respir. Dis. 1989; 139: 242-6.
46. Piedimonte G, Hoffman JIE, Hussein! WK, Snider RM, Desai MC, Nadel JA. NKi receptors mediate neurogenic inflammatory increase in blood flow in rat airways. J. Appl. Physiol. 1993; 74: 2462-8.
47. Piedimonte G, Hoffman JIE, Hussein! WK et al. Neurogenic vasodilatation in rat nasal mucosa involves neurokinin 1 tachykinin receptors. J. Phannacol. Exp. Ther. 1993; 265: 36-40.
48. Coleridge HM, Coleridge JC. Neural regulation of bronchial blood flow. Respir. Physiol. 1994; 98: 1-13.
49. Ichinose M, Mîura M, Yamauchi H et al. A neurokinin 1 receptor antagonist improves exercise induced airway narrowing in asthmatic patients. Am. J. Respir. Crit. Care Med. 1996; 153: 936-41.
50. Rogers DF, Aursudkij B, Bames PJ. Effects of tachykinins on mucus secretion on human bronchi in vitro. Eur. J. Phannacol. 1989; 174: 283-6.
51. Wiedermann FJ, Kahler CM, Reinisch N, Wiedermann CJ. Induction of normal human eosinophil migration in vitro by substance P. Ada Haematol. 1993; 89: 213-15.
52. Wozniak A, McLennan G, Betts WH, Murphy G, Scicchitano R. Activation of human neutrophils by SP: Effect on FMLP stimulated oxidative and arachidonic metabolism and on antibody-dependent cellmediated cytotoxicity. Immunology 1989; 68: 359-64.
53. Scicchitano R, Stanisz A, Bienenstock J. In vivo immunomodulation by the neuropeptide substance P. Immunology 1988; 63: 733-5.
54. Ali H, Leung KBP, Pearce FL, Hayes A, Foreman JC. Comparison of the histamine releasing action of substance Pon mast cells and basophils from different species and tissues. Int. Arch. Allergy Appl. Immwiol. 1983; 799: 121-4.
55. Heaney LG, Cross LJM, Stanford CF, Ennis M. Stimulation of bronchoalveolar lavage mast cells by substance P. Eur. Respir. J. 1993; 6 (Suppl. 17): S435 (Abstract).
56. Okamoto Y, Shirotori K, Kudo K et al. Cytokine expression after the topical administration of substance P to human nasal mucosa. The role of substance P in nasal allergy. J. Immunol. 1993; 151: 4391-8.
57. Von Essen SG, Rennard SI, O'Neill D et al. Bronchial epithelial cells release neutrophil chemotactic activity in response to tachykinins. Am. J. Physiol. 1992; 263: L226-31.
58. Baluk P, Bertrand C, Geppetti P, McDonald DM, Nadel JA. NKi receptors mediate leukocyte adhesion in neurogenic inflammation in the rat trachea. Am. J. Physiol. 1995; 268: L263-9.
59. DeRose V, Robbins RA, Snider RM et al. Substance P increases neutrophil adhesion to bronchial epithelial cells. J. Imnumol. 1994; 152: 1339-46.
60. D'Ortho M-P, Jarreau P-H, Delacourt C et at. Tachykinins induce gelatinase production by guinea pig alveolar macrophages: Involvement of NK2 receptors. Am. J. Physiol. 1995; 269: L631-6.
61. Harrison NK, Dawes KE, Kwon OJ, Bames PJ, Laurent GJ, Chung KF. Effects of neuropeptides on human lung fibroblast proliferation and chemotaxis. Am. J. Physiol. 1995; 268: L278-83.
62. Kirn JS, Rabe KF, Magnussen H, Green JM, White SR. Migration and proliferation of guinea pig and human airway epithelial cells in response to tachykinins. Am. J. Physiol. 1995; 269: LI 19-26.
63. Noveral JP, Grunstein M. Tachykinin regulation of airway smooth muscle cell proliferation. Am. J. Physiol. 1995; 269: L339-43.
64. Fan TP, Hu DE, Guard S, Gresham GA, Walling KJ. Stimulation of angiogenesis by substance P and interleukin 1 in the rat and its inhibition by NK| or interleukin receptor antagonists. Br. J. Phannacol. 1993; 110: 43-9.
65. Long NC, Shore S. Effect of capsaicin pretreatment on bronchoalveolar cells from rats during SÜ2 induction of chronic bronchitis. Am. Rev. Respir. Dis. 1993; 147: A72.
66. Bowden JJ, Baluk P, Lefevre PM, Schoeb TR, Lindsey JR, McDonald DM. Sensory denervation by neonatal capsaicin treatment exacerbates Mycoplasma pulmonis infection in rat airways. Am. J. Physiol. 1996; 270: L393-404.
67. Killingsworth CR, Paulauskis JD, Shore S. Substance P content and preprotachykinin gene-1 expression in a rat model of chronic bronchitis. Am. J. Respir. Cell Mol. Biol. 1996; 14: 334-40.
68. Ollerenshaw S, Jarvis DL, Sullivan CE, Woolcock AJ. Substance P immunoreactive nerve fibres in airways from asthmatics and nonasthmatics. EUT. Respir. J. 1991; 4: 673-82.
69. Howarth PH, Djukanovic R, Wilson JW, Holgate ST, Springall DR, Polak JM. Mucosal nerves in endobronchial biopsies in asthma and nonasthma. Int. Arch. Allergy Appl. Immunol. 1991; 94: 330-3.
70. Lilly CM, Bai TR, Shore SA, Hall AE, Drazen JM. Neuropeptide content of lungs from asthmatic and nonasthmatic patients. Am. J. Respir. CriJ. Care Med. 1995; 151: 548-53.
71. Nieber K, Baumgarten CR, Rathsack R, Furkert J, Oehme P, Kunkel G. Substance P and -endorphin-like immunoreactivity in lavage fluids in subjects with and without allergic asthma. J. Allergy Clin. Immunol. 1992; 90: 646-52.
72. Mosimann BL, White MV, Hohman RJ, Goldrich MS, Kaulbach HC, Kaliner MA. Substance P, calcitonin gene related peptide and vasoactive intestinal peptide increase in nasal secretions after allergen challenge in atopic patients. J. Allergy Clin. Immunol. 1993; 92:95-104.
73. Tomaki M, Ichinose M, Miura M et al. Elevated substance P content in induced sputum from patients with asthma and patients with chronic bronchitis. Am. J. Respir. CriJ. Care Med. 1995; 151: 613-17.
74. O'Connell F, Springall DR, Moradoghli-Haftvani A et al. Abnormal intraepithelial airway nerves in persistent unexplained cough? Am. J. Respir. Crit. Care Med. 1995; 152: 2068-75.
75. Adcock IM, Peters M, Gelder CM, Shirasaki H, Brown PR, Barnes PJ. Increased tachykinin receptor gene expression in asthmatic lung and its modulation by steroids. J. Mol. Endocrinol. 1993; 11: 1-7.
76. Nadel JA. Regulation of neurogenic inflammation by neutral endopeptidase. .Am. Rev. Respir. Dis. 1992; 145: S48-52.
77. Devillier P, Advenier C, Drapeau G, Marsac J, Regoli D. Comparison of the effects of epithelium removal and of an enkephalinase inhibitor on the neurokinin-induced contractions of guinea-pig isolated trachea. Br. J. Phannacol. 1988; 94: 675-84.
78. Lang Z, Murlas CG. Neutral endopeptidase of a human airway epithelial cell line recovers after hypochlorus acid exposure: Dexamethasone accelerates this by stimulating neutral endopeptidase mRNA synthesis. Am. J. Respir. Cell. Mol. Biol. 1992; 7: 300-6.
79. Kohrogi H, Nadel JA, Malfroy B et al. Recombinant human enkephalinase (neutral endopeptidase) prevents cough induced by tachykinins in awake guinea pigs. J. Clin. Invest. 1990; 84: 781-6.
80. Crimi N, Polosa R, Pulvirenli G et al. Effect of an inhaled neutral endopeptidase inhibitor, phosphoramidon, on baseline airway calibre and bronchial responsiveness to bradykinin in asthma. Thorax 1995; 50: 505-10.
81. Ichinose M, Nakajima N, Takahari T, Yamauchi H, Inoue H, Takishima T. Protection against bradykinin induced bronchoconstriction in asthmatic patients by a neurokinin receptor antagonist. Lancet 1992; 340: 1248-51.
82. Joos OF, Van Schoor J, Kips JC, Pauwels RA. The effect of inhaled FK224, a tachykinin NKi and NK2 antagonist, on neurokinin A-induced bronchoconstriction in asthmatics. Am. J. Respir. Crit. CareMed. 1996; 153: 1781-4.
83. Joos GF, Kips JC, Peleman RA, Pauwels RA. Tachykinin antagonists and the airways. Arch. Int. Pharmacodyn. Ther. 1995; 329: 205-19.
84. Joos GF, Pauwels RA, Van Der Staeten ME. The effect of nedocromil sodium on the bronchoconstrictor effect of neurokinin A in subjects with asthma. J. Allergy din. Immunol. 1989; 83: 663-8.
85. Crimi N, Palermo F, Oliven R, Palermo B, Polosa R, Mistretta A. Protection of nedocromil sodium on bronchconstriction induced by inhaled neurokinin A in asthmatic patients. Clin. Exp. Allergy 1992; 22: 75-81.